Rockwell Financial Statements From 2010 to 2025

RMTI Stock  USD 1.73  0.04  2.26%   
Rockwell Medical financial statements provide useful quarterly and yearly information to potential Rockwell Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Rockwell Medical financial statements helps investors assess Rockwell Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Rockwell Medical's valuation are summarized below:
Gross Profit
16.7 M
Profit Margin
(0.01)
Market Capitalization
57.2 M
Enterprise Value Revenue
0.514
Revenue
98.9 M
We have found one hundred twenty available trending fundamental ratios for Rockwell Medical, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Rockwell Medical recent fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 37.7 M. Enterprise Value is estimated to decrease to about 41.5 M

Rockwell Medical Total Revenue

100.96 Million

Check Rockwell Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rockwell Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1 M, Interest Expense of 2.5 M or Total Revenue of 101 M, as well as many indicators such as Price To Sales Ratio of 0.45, Dividend Yield of 0.0 or PTB Ratio of 1.77. Rockwell financial statements analysis is a perfect complement when working with Rockwell Medical Valuation or Volatility modules.
  
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.

Rockwell Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets37.3 M60 M52.2 M
Pretty Stable
Short and Long Term Debt Total16.2 M15.5 M9.9 M
Slightly volatile
Other Current Liabilities11.9 M11.4 M5.8 M
Slightly volatile
Total Current Liabilities9.7 M19.1 M13.7 M
Pretty Stable
Property Plant And Equipment Net13.3 M12.7 M5.2 M
Slightly volatile
Accounts Payable4.1 M5.2 M5.2 M
Slightly volatile
Cash13.5 M10.3 M18.5 M
Very volatile
Non Current Assets Total28.3 M26.9 M10.2 M
Slightly volatile
Non Currrent Assets Other1.1 M810.8 K1.7 M
Very volatile
Cash And Short Term Investments21.9 M12.6 M31.3 M
Very volatile
Net Receivables13.2 M12.5 M6.3 M
Slightly volatile
Common Stock Shares Outstanding28.2 M26.8 M8.6 M
Slightly volatile
Liabilities And Stockholders Equity37.3 M60 M52.2 M
Pretty Stable
Inventory3.8 M6.8 M4.9 M
Slightly volatile
Other Current Assets1.1 M1.2 M1.5 M
Slightly volatile
Other Stockholder Equity505.3 M481.3 M188.5 M
Slightly volatile
Total Liabilities18.1 M35.5 M27.8 M
Slightly volatile
Property Plant And Equipment Gross23.9 M22.8 M7.8 M
Slightly volatile
Total Current Assets31.1 M33.1 M43.5 M
Very volatile
Short Term Debt1.8 M2.5 M3.4 M
Pretty Stable
Intangible Assets13 M12.4 M4.5 M
Slightly volatile
Common Stock Total Equity9.8 K10.3 K104.5 M
Slightly volatile
Other Assets16.7 M15.9 M5.2 M
Slightly volatile
Good Will742.2 K828.9 K914.2 K
Slightly volatile
Non Current Liabilities Total9.8 M16.4 M15.3 M
Slightly volatile
Property Plant Equipment10.4 M9.9 M5.1 M
Slightly volatile
Warrants5.1 M4.4 M5.3 M
Slightly volatile
Long Term Debt Total21.6 M20.6 M16.1 M
Slightly volatile
Capital Lease Obligations4.7 M5.6 M3.7 M
Slightly volatile
Other Liabilities2.2 M2.4 M12.3 M
Slightly volatile
Net Invested Capital24.4 M26.8 M30.9 M
Slightly volatile
Net Working Capital10.4 M10.9 M31.1 M
Slightly volatile
Capital Stock2.6 K2.7 K168.5 M
Slightly volatile
Capital Surpluse384.1 M427.2 M347.8 M
Slightly volatile
Short and Long Term Debt208.6 K219.6 K1.6 M
Pretty Stable

Rockwell Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue101 M96.2 M61.1 M
Slightly volatile
Other Operating Expenses61.1 M103.8 M81 M
Slightly volatile
Cost Of Revenue90.5 M86.1 M56 M
Slightly volatile
Total Operating Expenses19.7 M17.7 M28.1 M
Slightly volatile
Selling General Administrative12.4 M14 M15.6 M
Pretty Stable
Research Development1.2 M1.3 M10.3 M
Slightly volatile
Interest Income257.7 K189.9 K422.3 K
Slightly volatile
Reconciled Depreciation2.2 M3.5 M1.5 M
Slightly volatile
Non Recurring367.6 K387 K1.4 M
Slightly volatile
Selling And Marketing Expenses1.8 M1.9 MM
Slightly volatile

Rockwell Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation1.1 M1.7 M1.3 M
Slightly volatile
Capital Expenditures310.3 K326.6 K685.5 K
Pretty Stable
End Period Cash Flow13.2 M10.3 M17.9 M
Very volatile
Begin Period Cash Flow13.1 M11.6 M18 M
Pretty Stable
Stock Based Compensation796.9 K838.8 K4.4 M
Slightly volatile
Change To Netincome782.3 K823.5 K5.3 M
Slightly volatile
Issuance Of Capital Stock18.1 M12.4 M21.4 M
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.450.473.5435
Slightly volatile
Days Sales Outstanding40.6942.831.6 K
Very volatile
Average Payables2.5 M3.4 M3.9 M
Pretty Stable
Stock Based Compensation To Revenue0.01220.01280.0794
Slightly volatile
Capex To Depreciation0.210.230.7038
Pretty Stable
EV To Sales0.50.523.3675
Slightly volatile
Inventory Turnover9.8211.4812.4349
Pretty Stable
Days Of Inventory On Hand37.8132.935.0269
Very volatile
Payables Turnover8.5814.9311.44
Slightly volatile
Sales General And Administrative To Revenue0.20.130.262
Pretty Stable
Average Inventory5.6 M5.3 M4.7 M
Slightly volatile
Research And Ddevelopement To Revenue0.01450.01520.2021
Slightly volatile
Capex To Revenue0.00370.00390.0223
Slightly volatile
Cash Per Share0.40.426.7173
Slightly volatile
Days Payables Outstanding46.5525.3143.6838
Slightly volatile
Intangibles To Total Assets0.270.260.083
Slightly volatile
Current Ratio2.621.563.7149
Pretty Stable
Receivables Turnover7.536.99.4203
Pretty Stable
Capex Per Share0.01330.0140.2322
Slightly volatile
Average ReceivablesB1.9 B903.3 M
Slightly volatile
Revenue Per Share3.924.1212.0305
Slightly volatile
Interest Debt Per Share0.580.611.4831
Very volatile
Debt To Assets0.140.230.1902
Slightly volatile
Graham Number2.293.323.3926
Pretty Stable
Operating Cycle65.1568.581.6 K
Very volatile
Days Of Payables Outstanding46.5525.3143.6838
Slightly volatile
Ebt Per Ebit0.761.141.0425
Very volatile
Long Term Debt To Capitalization0.260.250.7
Slightly volatile
Quick Ratio2.271.243.3104
Pretty Stable
Net Income Per E B T0.820.990.9972
Very volatile
Cash Ratio0.460.491.5196
Pretty Stable
Days Of Inventory Outstanding37.8132.935.0269
Very volatile
Days Of Sales Outstanding40.6942.831.6 K
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.31.181.0784
Very volatile
Fixed Asset Turnover12.586.8318.9292
Slightly volatile
Debt Ratio0.140.230.1902
Slightly volatile
Price Sales Ratio0.450.473.5435
Slightly volatile
Asset Turnover1.761.841.3187
Pretty Stable

Rockwell Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap37.7 M39.7 M161.2 M
Slightly volatile
Enterprise Value41.5 M43.7 M150.5 M
Slightly volatile

Rockwell Fundamental Market Drivers

Forward Price Earnings59.1716
Cash And Short Term Investments10.9 M

Rockwell Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Rockwell Medical Financial Statements

Investors use fundamental indicators, such as Rockwell Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Rockwell Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue52.9 K50.3 K
Total Revenue96.2 M101 M
Cost Of Revenue86.1 M90.5 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.13  0.20 
Research And Ddevelopement To Revenue 0.02  0.01 
Revenue Per Share 4.12  3.92 
Ebit Per Revenue(0.09)(0.10)

Currently Active Assets on Macroaxis

When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.04)
Revenue Per Share
3.296
Quarterly Revenue Growth
0.191
Return On Assets
0.0066
Return On Equity
(0.05)
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.